External Validation, Domain Shift, and Institutional Non-Exchangeability as the Primary Translational Constraint in Clinical Predictive Modeling

Abstract

Clinical prediction research has entered a period in which the technical capacity to generate risk models is expanding faster than the capacity to establish whether those models will remain useful outside their development setting. Hospitals now produce extensive streams of perioperative, physiological, administrative, imaging, and laboratory data, and these data support increasingly sophisticated forms of statistical learning. Yet the environments in which such models are expected to operate are not interchangeable. Institutions differ in referral pathways, measurement intensity, coding practices, escalation thresholds, postoperative surveillance, and treatment timing. As a result, a model that appears accurate in retrospective development may fail to preserve calibration, ranking stability, or decision usefulness when transported to another clinical context. This paper develops the claim that generalizability and external validation should be treated as the principal translational problem rather than as a secondary reporting requirement. The analysis frames deployment as an exercise in estimation under institutional non-exchangeability, where the target quantity is not merely source-domain prediction loss but expected performance under heterogeneous, evolving, and intervention-sensitive environments. A formal account of transport failure is presented using multi-domain risk functionals, spectral representations of institutional variation, and decision-theoretic threshold analysis. The paper further examines how selection mechanisms, missingness structure, measurement heterogeneity, temporal drift, and intervention feedback destabilize apparently strong predictors. It then proposes a transport-first validation architecture centered on multi-site estimation, domain-wise calibration analysis, uncertainty quantification, and prospective policy testing. The broader conclusion is that translational success depends less on extracting maximal local fit than on demonstrating that model behavior remains coherent under the forms of variation that characterize real clinical systems.